Posted by Michael Wonder on 12 Sep 2021
Biden Administration’s prescription drug pricing plan promotes incremental change, not overhaul of system
12 September 2021 - On Thursday, September 9th, the White House released a long awaited plan to reduce prescription drug prices and out of pocket costs for patients.
The plan is more conspicuous for what it doesn’t tackle, or leaves unsaid, than what it addresses (mostly) indirectly and incrementally.
The report asserts that prescription drug prices in the U.S. are “too high,” putatively due to lack of competition.
